MEDI1814, A HIGH-AFFINITY ANTIBODY DIRECTED TO THE C-TERMINUS OF AβX-42, ABROGATES SYNAPTIC PLASTICITY DISRUPTION CAUSED BY SYNTHETIC OR AD BRAIN-DERIVED Aβ SOLUBLE ASSEMBLIES IN VIVO